Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1982 2
1983 5
1984 2
1985 2
1986 1
1988 2
1989 3
1990 1
1992 2
1993 2
1994 1
1995 1
1996 2
1997 2
1998 4
1999 4
2000 2
2001 2
2002 5
2003 6
2004 6
2005 2
2006 3
2007 6
2008 6
2009 2
2010 6
2011 6
2012 7
2013 11
2014 7
2015 9
2016 6
2017 14
2018 20
2019 13
2020 26
2021 21
2022 17
2023 20
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

239 results

Results by year

Filters applied: . Clear all
Page 1
Frequent pathway mutations of splicing machinery in myelodysplasia.
Yoshida K, Sanada M, Shiraishi Y, Nowak D, Nagata Y, Yamamoto R, Sato Y, Sato-Otsubo A, Kon A, Nagasaki M, Chalkidis G, Suzuki Y, Shiosaka M, Kawahata R, Yamaguchi T, Otsu M, Obara N, Sakata-Yanagimoto M, Ishiyama K, Mori H, Nolte F, Hofmann WK, Miyawaki S, Sugano S, Haferlach C, Koeffler HP, Shih LY, Haferlach T, Chiba S, Nakauchi H, Miyano S, Ogawa S. Yoshida K, et al. Among authors: obara n. Nature. 2011 Sep 11;478(7367):64-9. doi: 10.1038/nature10496. Nature. 2011. PMID: 21909114
Addition of danicopan to ravulizumab or eculizumab in patients with paroxysmal nocturnal haemoglobinuria and clinically significant extravascular haemolysis (ALPHA): a double-blind, randomised, phase 3 trial.
Lee JW, Griffin M, Kim JS, Lee Lee LW, Piatek C, Nishimura JI, Carrillo Infante C, Jain D, Liu P, Filippov G, Sicre de Fontbrune F, Risitano A, Kulasekararaj AG; ALXN2040-PNH-301 Investigators. Lee JW, et al. Lancet Haematol. 2023 Dec;10(12):e955-e965. doi: 10.1016/S2352-3026(23)00315-0. Lancet Haematol. 2023. PMID: 38030318 Clinical Trial.
[Overview].
Obara N. Obara N. Rinsho Ketsueki. 2021;62(5):370. doi: 10.11406/rinketsu.62.370. Rinsho Ketsueki. 2021. PMID: 34108316 Japanese. No abstract available.
The fatty acid elongase Elovl6 is crucial for hematopoietic stem cell engraftment and leukemia propagation.
Kiyoki Y, Kato T, Kito S, Matsuzaka T, Morioka S, Sasaki J, Makishima K, Sakamoto T, Nishikii H, Obara N, Sakata-Yanagimoto M, Sasaki T, Shimano H, Chiba S. Kiyoki Y, et al. Among authors: obara n. Leukemia. 2023 Apr;37(4):910-913. doi: 10.1038/s41375-023-01842-y. Epub 2023 Mar 8. Leukemia. 2023. PMID: 36890291 Free PMC article. No abstract available.
Safety of romiplostim administered immediately after cord-blood transplantation: a phase 1 trial.
Kurita N, Nishikii H, Maruyama Y, Suehara Y, Hattori K, Sakamoto T, Kato T, Yokoyama Y, Obara N, Maruo K, Ohigashi T, Yamaguchi H, Iwamoto T, Minohara H, Matsuoka R, Hashimoto K, Sakata-Yanagimoto M, Chiba S. Kurita N, et al. Among authors: obara n. Ann Hematol. 2023 Oct;102(10):2895-2902. doi: 10.1007/s00277-023-05410-3. Epub 2023 Aug 17. Ann Hematol. 2023. PMID: 37589942 Clinical Trial.
[Acute myeloid leukemia harboring NUP98::DDX10].
Kurita N, Kato T, Nanmoku T, Maruyama Y, Suehara Y, Hattori K, Sakamoto T, Yokoyama Y, Yoshida C, Tsuboi Y, Obara N, Nishikii H, Sakata-Yanagimoto M, Chiba S. Kurita N, et al. Among authors: obara n. Rinsho Ketsueki. 2022;63(10):1397-1401. doi: 10.11406/rinketsu.63.1397. Rinsho Ketsueki. 2022. PMID: 36351646 Japanese.
239 results